New prescription drugs that spur weight loss and take care of diabetes have been having the public—plus the pharmaceutical sector—by storm. The newest entrant, Zepbound, not long ago joined Ozempic, Wegovy, Victoza and Many others in the increasing class of medicines referred to as GLP-1 receptor agonists.Your health practitioner may well presc